This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Choosing the right retirement account at 30 can be challenging. Learn about the different options available to make the best choice for your future.
22,749 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Tesla delivered 480,126 vehicles in Q2 2026, topping estimates by 74,000 and signaling a rebound in EV demand. The fo...
Could Micron Technology stock reach 2000 within a year? This article breaks down the catalysts, the math, and the ris...
Meta’s aggressive AI infrastructure push is drawing scrutiny, but a SpaceX-like monetization model could flip the scr...
A dedicated pure-miner uranium fund has jumped 61% this year, outpacing broader uranium plays. Analysts say the move ...
A single bullish call can spark excitement, but savvy investors know that big upside ideas demand rigorous scrutiny. ...
Wall Street chatter about a SpaceX and Tesla merger has sparked a wave of questions. This article unpacks what the ph...
AlleyCorp unveils a new $335 million fund focused on early-stage bets in healthcare and technology. The move reinforc...
Bitcoin faces a steep uphill climb after last year’s peak left early buyers in the red. Analysts say a near 90% rally...
Two families file a civil case after DNA tests revealed a birth swap at Unity Medical Center in 1988, challenging hos...
Buffett’s moat mindset helps explain Netflix's AI edge. This article breaks down why the advantage may be temporary a...
Live Nation Entertainment faces an earnings day that could swing the stock. This guide breaks down the catalysts, ris...